Advanced glycation end products and their receptors in serum of patients with type 2 diabetes
Abstract Glycation is a non-enzymatic process involving the reaction of reducing sugars or reactive oxoaldehyde with proteins, lipids or nucleic acids, which results in the formation of advanced glycation end products (AGEs). The presented work discusses the glycation process in people with advanced...
Saved in:
Main Authors: | Diana Indyk, Agnieszka Bronowicka-Szydełko, Andrzej Gamian, Aleksandra Kuzan |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/28fe6f922a48497f9a0698bb45ec8f3d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced glycation end products as predictors of renal function in youth with type 1 diabetes
by: Josephine M. Forbes, et al.
Published: (2021) -
Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.
by: Tássia Kirchmann Lazzari, et al.
Published: (2021) -
The melibiose-derived glycation product mimics a unique epitope present in human and animal tissues
by: Magdalena Staniszewska, et al.
Published: (2021) -
Advanced Glycation End-Products in Skeletal Muscle Aging
by: Lucas C. Olson, et al.
Published: (2021) -
Berberine suppresses advanced glycation end products‐associated diabetic retinopathy in hyperglycemic mice
by: Ning Wang, et al.
Published: (2021)